The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Lipfendra
Lipfendra · ENLICITIDE DECANOATE 20 mg/1 · Tablet, Film Coated · Oral · Merck Sharp & Dohme LLC
NDC 00006-5084-59 · 1 BOTTLE in 1 CARTON / 7 TABLET, FILM COATED in 1 BOTTLE · NDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- NDA220848
- TE code
- —
- Approval date
- Jul 15, 2026
- Patents / exclusivity
- 1 patents, 1 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | NCE | Jul 15, 2031 |
| patent | 11427616 | Feb 4, 2040 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Lipfendra (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Merck Sharp & Dohme LLC | ENLICITIDE DECANOATE 20 mg/1 | Jul 29, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Lipfendra — NDC 00006-5084-59," retrieved September 3, 2026, https://drugdashboards.com/drug/00006508459.
Free to cite with attribution — see how the data is put together.